Estimating cardiovascular risk and all-cause mortality in individuals with type 2 diabetes using the UKPDS Outcomes Model

Estimating cardiovascular risk and all-cause mortality in individuals with type 2 diabetes using the UKPDS Outcomes Model

Bibliográfalaš dieđut
Váldodahkkit:	Coleman, RL, Gray, AM, McGuire, DK, Holman, RR
Materiálatiipa:	Conference item
Giella:	English
Almmustuhtton:	Springer Nature 2019

Geahča maid

Increased risk of incident heart failure and all-cause mortality in insulin-resistant people with type 2 diabetes in the United Kingdom Prospective Diabetes Study (UKPDS)
Dahkki: Wamil, M, et al.
Almmustuhtton: (2020)

Estimating cardiovascular disease risk for individuals with Type 2 diabetes: the new UKPDS Risk Engine
Dahkki: Coleman, R, et al.
Almmustuhtton: (2007)

Estimating risk factor progression equations for the UKPDS Outcomes Model 2 (UKPDS 90)
Dahkki: Leal, J, et al.
Almmustuhtton: (2021)

Historical HbA1c values may explain the type 2 diabetes legacy effect: UKPDS 88
Dahkki: Lind, M, et al.
Almmustuhtton: (2021)

The impact of diabetes-related complications on healthcare costs: new results from the UKPDS (UKPDS 84).
Dahkki: Alva, M, et al.
Almmustuhtton: (2014)

Increased risk of incident heart failure and death is associated with insulin resistance in people with newly diagnosed type 2 diabetes: UKPDS 89
Dahkki: Wamil, M, et al.
Almmustuhtton: (2021)

Estimating risk of clinically evident neuropathy in Type 2 diabetes: a UKPDS risk equation
Dahkki: Coleman, R, et al.
Almmustuhtton: (2006)

Performance of the UKPDS Risk Engine and the Framingham risk equations in estimating cardiovascular disease in the EPIC-Norfolk cohort
Dahkki: Simmons, R, et al.
Almmustuhtton: (2008)

Framingham equations underestimate cardiovascular risk compared with the UKPDS risk engine in people with Type 2 diabetes
Dahkki: Price, H, et al.
Almmustuhtton: (2007)

Incident nephropathy in type 2 diabetes: a UKPDS Risk Equation
Dahkki: Coleman, R, et al.
Almmustuhtton: (2005)

Cardiovascular risk estimated by UKPDS risk engine algorithm in diabetes
Dahkki: Kavaric Nebojsa, et al.
Almmustuhtton: (2018-12-01)

Post-trial monitoring of a randomised controlled trial of intensive glycaemic control in type 2 diabetes extended from 10 years to 24 years (UKPDS 91)
Dahkki: Adler, AI, et al.
Almmustuhtton: (2024)

A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68).
Dahkki: Clarke, P, et al.
Almmustuhtton: (2004)

Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62).
Dahkki: Clarke, P, et al.
Almmustuhtton: (2002)

Risk factors for neuropathy in UKPDS
Dahkki: Stratton, I, et al.
Almmustuhtton: (2004)

Relationship between the severity of retinopathy and progression to photocoagulation in patients with Type 2 diabetes mellitus in the UKPDS (UKPDS 52).
Dahkki: Kohner, E, et al.
Almmustuhtton: (2001)

Ethnic differences in diabetic nephropathy - The UKPDS
Dahkki: Stevens, R, et al.
Almmustuhtton: (1999)

Metformin as first choice in oral diabetes treatment: the UKPDS experience.
Dahkki: Holman, R
Almmustuhtton: (2007)

Hypoglycaemia in patients with Type 2 diabetes in the UKPDS
Dahkki: Cull, C, et al.
Almmustuhtton: (2001)

Ethnicity and long-term vascular outcomes in Type 2 diabetes: a prospective observational study (UKPDS 83).
Dahkki: Davis, T, et al.
Almmustuhtton: (2014)

Ethnicity and long-term vascular outcomes in Type 2 diabetes: A prospective observational study (UKPDS 83)
Dahkki: Davis, T, et al.
Almmustuhtton: (2014)

UKPDS: what was the question? UK Prospective Diabetes Study.
Dahkki: Turner, R, et al.
Almmustuhtton: (1999)

Modelling incremental benefits on complications rates when targeting lower HbA1c levels in people with Type 2 diabetes and cardiovascular disease
Dahkki: Mostafa, SA, et al.
Almmustuhtton: (2017)

Life-expectancy projection by modelling and computer simulation (UKPDS 46).
Dahkki: Stevens, R, et al.
Almmustuhtton: (2000)

Insulin sensitivity at diagnosis of Type 2 diabetes is not associated with subsequent cardiovascular disease (UKPDS 67).
Dahkki: Adler, A, et al.
Almmustuhtton: (2005)

Evaluating SCORE and Framingham fatal coronary heart disease risk equations using UKPDS data
Dahkki: Coleman, R, et al.
Almmustuhtton: (2004)

Forecasting coronary case fatality in type 2 diabetes: a UKPDS Risk Engine equation
Dahkki: Stevens, R, et al.
Almmustuhtton: (2002)

Changing aspirin use in patients with Type 2 diabetes in the UKPDS.
Dahkki: Cull, C, et al.
Almmustuhtton: (2004)

UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group.
Dahkki: Matthews, DR, et al.
Almmustuhtton: (1998)

Could non-HDL cholesterol replace total/HDL cholesterol ratio to estimate coronary heart disease risk in the UKPDS risk engine?
Dahkki: Stevens, R, et al.
Almmustuhtton: (2004)

Inaugural Conference: UKPDS Legacy and Precision Therapy for Type 2 Diabetes Mellitus
Dahkki: Rury Holman
Almmustuhtton: (2022-09-01)

Prognostic significance of silent myocardial infarction in newly diagnosed type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 79.
Dahkki: Davis, T, et al.
Almmustuhtton: (2013)

Predictive value of estimated pulse wave velocity for cardiovascular and all-cause mortality in individuals with obesity
Dahkki: Daidi Li, et al.
Almmustuhtton: (2023-03-01)

Hyperglycemia and hyperinsulinemia at diagnosis of diabetes and their association with subsequent cardiovascular disease in the United Kingdom prospective diabetes study (UKPDS 47).
Dahkki: Adler, A, et al.
Almmustuhtton: (1999)

Estimating the quality of life impact of diabetes related complications: new results from the UKPDS
Dahkki: Alva, M, et al.
Almmustuhtton: (2010)

Risk factors for incident albuminuria and renal dysfunction in the UKPDS
Dahkki: Adler, A, et al.
Almmustuhtton: (2000)

UKPDS outcomes model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS 82.
Dahkki: Hayes, A, et al.
Almmustuhtton: (2013)

UKPDS Outcomes Model 2: A new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year united kingdom prospective diabetes Study: UKPDS 82
Dahkki: Hayes, A, et al.
Almmustuhtton: (2013)

The associations of cardiovascular health and all-cause mortality among individuals with depression
Dahkki: Meili Li, et al.
Almmustuhtton: (2025-01-01)

Temporal validation of the UKPDS outcomes model using 10-year posttrial monitoring data.
Dahkki: Leal, J, et al.
Almmustuhtton: (2013)